Carbgem Supports 'AI for Science': Launches AI Implementation Consulting Service Specialized in Life Sciences and Healthcare
In response to MEXT's 'AI for Science' initiative, Carbgem Inc. has launched an AI implementation consulting service for researchers in the life science and medical fields. Leveraging their cloud AI platform 'CarbConnect®' and expertise in medical software development, they support the entire process from Proof of Concept (PoC) to societal implementation.
📋 Article Processing Timeline
- 📰 Published: May 19, 2026 at 18:52
- 🔍 Collected: May 19, 2026 at 10:31
- 🤖 AI Analyzed: May 19, 2026 at 11:06 (34 min after Collected)
Carbgem Inc. (Headquarters: Shibuya-ku, Tokyo, Representative Director: Masakazu Nakajima, hereinafter referred to as 'the Company') announced today the launch of 'AI for Science Consulting Support', an AI implementation service targeted at researchers in the life science and medical fields. This service is designed to be a consulting partner for researchers tackling AI for Science, responding to the 'Basic Strategic Policy for Promoting AI for Science' formulated by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) on March 31, 2026, and the related 'Scientific Research Innovation Program using AI for Science' (including the Innovative Research Promotion Project (ARiSE) and the Sprouting Challenge Research Creation Project (SPReAD)). By integrating the Company's proprietary cloud AI model development platform, 'CarbConnect®', with the regulatory and QMS expertise cultivated through the development of Software as a Medical Device (SaMD), we aim to accelerate AI implementation in life science research settings.
AI for Science
Service introduction page: https://carbgem.com/carbgem_ai_for_science_lp/
◆ Background of Development
In recent years, the trend of 'AI for Science'—utilizing AI to advance and accelerate scientific research—has been expanding globally. In Japan, MEXT formulated the 'Basic Strategic Policy for Promoting AI for Science' in March 2026. Based on this policy, they launched the 'Scientific Research Innovation Program using AI for Science', which includes the flagship 'ARiSE' project and the broader 'SPReAD' project, aiming to support researchers in accelerating their use of AI.
Specifically, the SPReAD project is built on three pillars: '1. Rapid support, 2. Consulting support necessary for AI implementation, and 3. Support for nurturing original research', opening doors for researchers who previously had little interaction with AI. However, challenges still persist in research settings:
- AI models often stall at the PoC (Proof of Concept) stage and fail to reach societal implementation.
- High hurdles exist in securing computational resources and complying with pharmaceutical affairs and quality management.
- There is a scarcity of development partners who understand the unique data structures and research processes specific to life sciences and healthcare.
The Company has a proven track record in industry-academia-government collaboration, including the joint development of the Software as a Medical Device (SaMD) 'BiTTE®-Urine'* with the Japan Institute for Health Security (JIHS) and Kobe University, as well as joint research with the Graduate School of Agricultural and Life Sciences, The University of Tokyo. By packaging this knowledge, we have structured an end-to-end consulting service that supports researchers from PoC to societal implementation when they embark on AI for Science projects.
*Software as a Medical Device (SaMD) 'BiTTE®-Urine': (Approval Number: 30600BZX00247000, Manufacturer and Distributor: Carbgem Inc. Tokyo Data Lab, Marketing Authorization Holder: Nexgem Inc. Tokyo Data Lab)
◆ Main Features of the Service
■ 1. Specialized Expertise in Life Sciences and Healthcare
Understanding the unique data structures and research processes of the life science and medical fields—such as medical image analysis, genome analysis, drug discovery target exploration, and simulations—we propose the optimal AI model design tailored to specific challenges.
■ 2. Societal Implementation Support Leveraging SaMD and Regulatory Experience
A team with a proven track record in medical device software development, QMS construction, and regulatory review provides consulting support looking ahead to the societal implementation phase of research results.
■ 3. Utilization of the Cloud AI Model Development Platform 'CarbConnect®'
By utilizing 'CarbConnect®', a cloud platform capable of centrally developing, verifying, and operating AI models in a secure environment, we achieve a one-stop solution for securing computational resources, data preparation, model development, and communication.
◆ Differences from General AI Development Support
- Domain Knowledge: (General AI Vendors) Cross-industry/General-purpose / (Our Company) Specialized in Life Sciences & Healthcare
- Regulatory/QMS Compliance: (General AI Vendors) Limited / (Our Company) Support based on SaMD approval track record
- Development Infrastructure: (General AI Vendors) Individual environments / (Our Company) Integrated environment via CarbConnect®
- Exit Strategy Design: (General AI Vendors) Up to PoC/Implementation / (Our Company) End-to-end, up to paper publication and societal implementation
- Implementation Hurdle: (General AI Vendors) Expensive/Long-term contracts / (Our Company) Starting from computational resource vouchers at ¥100,000~
AI for Science
Service introduction page: https://carbgem.com/carbgem_ai_for_science_lp/
◆ Background of Development
In recent years, the trend of 'AI for Science'—utilizing AI to advance and accelerate scientific research—has been expanding globally. In Japan, MEXT formulated the 'Basic Strategic Policy for Promoting AI for Science' in March 2026. Based on this policy, they launched the 'Scientific Research Innovation Program using AI for Science', which includes the flagship 'ARiSE' project and the broader 'SPReAD' project, aiming to support researchers in accelerating their use of AI.
Specifically, the SPReAD project is built on three pillars: '1. Rapid support, 2. Consulting support necessary for AI implementation, and 3. Support for nurturing original research', opening doors for researchers who previously had little interaction with AI. However, challenges still persist in research settings:
- AI models often stall at the PoC (Proof of Concept) stage and fail to reach societal implementation.
- High hurdles exist in securing computational resources and complying with pharmaceutical affairs and quality management.
- There is a scarcity of development partners who understand the unique data structures and research processes specific to life sciences and healthcare.
The Company has a proven track record in industry-academia-government collaboration, including the joint development of the Software as a Medical Device (SaMD) 'BiTTE®-Urine'* with the Japan Institute for Health Security (JIHS) and Kobe University, as well as joint research with the Graduate School of Agricultural and Life Sciences, The University of Tokyo. By packaging this knowledge, we have structured an end-to-end consulting service that supports researchers from PoC to societal implementation when they embark on AI for Science projects.
*Software as a Medical Device (SaMD) 'BiTTE®-Urine': (Approval Number: 30600BZX00247000, Manufacturer and Distributor: Carbgem Inc. Tokyo Data Lab, Marketing Authorization Holder: Nexgem Inc. Tokyo Data Lab)
◆ Main Features of the Service
■ 1. Specialized Expertise in Life Sciences and Healthcare
Understanding the unique data structures and research processes of the life science and medical fields—such as medical image analysis, genome analysis, drug discovery target exploration, and simulations—we propose the optimal AI model design tailored to specific challenges.
■ 2. Societal Implementation Support Leveraging SaMD and Regulatory Experience
A team with a proven track record in medical device software development, QMS construction, and regulatory review provides consulting support looking ahead to the societal implementation phase of research results.
■ 3. Utilization of the Cloud AI Model Development Platform 'CarbConnect®'
By utilizing 'CarbConnect®', a cloud platform capable of centrally developing, verifying, and operating AI models in a secure environment, we achieve a one-stop solution for securing computational resources, data preparation, model development, and communication.
◆ Differences from General AI Development Support
- Domain Knowledge: (General AI Vendors) Cross-industry/General-purpose / (Our Company) Specialized in Life Sciences & Healthcare
- Regulatory/QMS Compliance: (General AI Vendors) Limited / (Our Company) Support based on SaMD approval track record
- Development Infrastructure: (General AI Vendors) Individual environments / (Our Company) Integrated environment via CarbConnect®
- Exit Strategy Design: (General AI Vendors) Up to PoC/Implementation / (Our Company) End-to-end, up to paper publication and societal implementation
- Implementation Hurdle: (General AI Vendors) Expensive/Long-term contracts / (Our Company) Starting from computational resource vouchers at ¥100,000~
FAQ
What is Carbgem's 'AI for Science Support'?
A service for medical and life science researchers that provides end-to-end support from AI model design to regulatory compliance and real-world implementation.
What are its key strengths?
Unlike general AI development, it leverages expertise in SaMD (Software as a Medical Device) development and uses the dedicated 'CarbConnect®' platform.
Why was it launched now?
To align with MEXT's 'AI for Science' promotion policy established in March 2026 and the subsequent funding programs.